See more : Yanlord Land Group Limited (YLDGY) Income Statement Analysis – Financial Results
Complete financial analysis of Suzhou Zelgen Biopharmaceuticals Co., Ltd. (688266.SS) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Suzhou Zelgen Biopharmaceuticals Co., Ltd., a leading company in the Biotechnology industry within the Healthcare sector.
- Quantum-Si incorporated (QSIAW) Income Statement Analysis – Financial Results
- Sinko Industries Ltd. (6458.T) Income Statement Analysis – Financial Results
- Chesapeake Energy Corporation (CHKEL) Income Statement Analysis – Financial Results
- The Middleby Corporation (0K1G.L) Income Statement Analysis – Financial Results
- Engie Energia Chile S.A. (ECL.SN) Income Statement Analysis – Financial Results
Suzhou Zelgen Biopharmaceuticals Co., Ltd. (688266.SS)
About Suzhou Zelgen Biopharmaceuticals Co., Ltd.
Suzhou Zelgen Biopharmaceuticals Co., Ltd. researches and develops, manufactures, and sells medicines in the People's Republic of China. It offers small molecule and recombinant protein drugs for the treatment of liver cancer, non-small cell lung cancer, colorectal cancer, thyroid cancer, nasopharyngeal carcinomas, myelofibrosis, hemorrhage, and hepatobiliary diseases. The company was founded in 2009 and is based in Kunshan, the People's Republic of China.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 386.44M | 302.31M | 190.36M | 27.66M | 0.00 | 1.31M | 0.00 | 200.33K |
| Cost of Revenue | 31.42M | 26.16M | 6.27M | 27.48K | 33.27M | 893.90K | 5.09M | 159.80K |
| Gross Profit | 355.02M | 276.14M | 184.09M | 27.63M | -33.27M | 417.26K | -5.09M | 40.53K |
| Gross Profit Ratio | 91.87% | 91.35% | 96.71% | 99.90% | 0.00% | 31.82% | 0.00% | 20.23% |
| Research & Development | 496.33M | 497.73M | 509.39M | 314.20M | 183.84M | 142.81M | 158.82M | 61.08M |
| General & Administrative | -18.10M | 53.89M | 51.61M | 43.23M | 246.94M | 312.60M | 7.58M | 73.63M |
| Selling & Marketing | 119.40M | 227.69M | 139.74M | 35.07M | 7.83M | 0.00 | 0.00 | 0.00 |
| SG&A | 100.41M | 281.57M | 191.35M | 78.30M | 254.77M | 312.60M | 7.58M | 73.63M |
| Other Expenses | 0.00 | 666.99K | -14.02M | -6.83M | 1.66M | -10.00K | -1.15K | 5.37M |
| Operating Expenses | 652.80M | 779.97M | 686.72M | 385.67M | 440.27M | 446.10M | 148.33M | 134.97M |
| Cost & Expenses | 684.22M | 806.13M | 692.99M | 385.70M | 440.27M | 447.00M | 148.33M | 135.13M |
| Interest Income | 39.35M | 28.75M | 39.98M | 38.34M | 1.17M | 879.37K | 1.93M | 1.29M |
| Interest Expense | 24.45M | 12.03M | 4.42M | 1.09M | 1.16M | 30.61K | 0.00 | 0.00 |
| Depreciation & Amortization | 54.83M | 70.81M | 53.39M | 46.70M | 33.27M | 14.08M | 5.09M | 5.73M |
| EBITDA | -214.23M | -402.21M | -405.55M | -256.63M | -405.00M | -437.35M | -141.38M | -129.19M |
| EBITDA Ratio | -55.44% | -135.70% | -214.28% | -989.64% | 0.00% | -32,934.71% | 0.00% | -64,466.47% |
| Operating Income | -408.79M | -503.82M | -502.63M | -358.04M | -439.79M | -442.65M | -146.47M | -133.63M |
| Operating Income Ratio | -105.79% | -166.66% | -264.04% | -1,294.37% | 0.00% | -33,760.07% | 0.00% | -66,705.11% |
| Total Other Income/Expenses | 109.71M | -2.40M | -6.10M | -4.58K | 906.54 | -10.00K | -1.15K | 5.37M |
| Income Before Tax | -299.08M | -487.95M | -465.15M | -304.83M | -439.79M | -442.66M | -146.47M | -128.27M |
| Income Before Tax Ratio | -77.40% | -161.41% | -244.35% | -1,102.03% | 0.00% | -33,760.83% | 0.00% | -64,027.01% |
| Income Tax Expense | -3.95M | -2.01M | -3.16M | 5.84M | 8.20M | -780.38K | -56.99K | 44.32K |
| Net Income | -278.58M | -485.95M | -461.99M | -310.68M | -447.98M | -440.09M | -146.47M | -128.27M |
| Net Income Ratio | -72.09% | -160.75% | -242.69% | -1,123.16% | 0.00% | -33,564.91% | 0.00% | -64,027.01% |
| EPS | -1.09 | -2.02 | -1.92 | -1.29 | -1.87 | -2.45 | -0.81 | -0.71 |
| EPS Diluted | -1.09 | -2.02 | -1.92 | -1.29 | -1.87 | -2.45 | -0.81 | -0.71 |
| Weighted Avg Shares Out | 255.58M | 240.00M | 240.00M | 240.00M | 240.00M | 179.72M | 179.72M | 179.72M |
| Weighted Avg Shares Out (Dil) | 255.58M | 240.00M | 240.00M | 240.00M | 240.00M | 179.72M | 179.72M | 179.72M |
Source: https://incomestatements.info
Category: Stock Reports